Moscow, Russia

Grigorij G Rozancev

This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Grigorij G Rozancev. Retrieved from https://idiyas.com/inventor/grigorij-g-rozancev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Grigorij G Rozancev: Innovator in Cerebroprotective Compounds

Introduction

Grigorij G Rozancev is a notable inventor based in Moskau, SU. He has made significant contributions to the field of medicine, particularly in the development of compounds that have a pronounced cerebroprotective effect. His work is essential for the prophylaxis and treatment of cerebral functional disorders.

Latest Patents

Rozancev holds a patent for N-acyl-4-phenyl-pyrrolidin-2-ones and the method for preparing these compounds. This invention focuses on N-acetyl-4-phenyl-pyrrolidin-2-ones, which are synthesized by reacting 4-phenyl-pyrrolidin-2-ones with a reactive derivative of a carboxylic acid or by cyclizing N-acylaminobutyric acid derivatives. The compounds developed through this patent are crucial for addressing various cerebral functional disorders in human medicine.

Career Highlights

Throughout his career, Rozancev has been associated with Arzneimittelwerk Dresden GmbH, where he has contributed to the advancement of pharmaceutical innovations. His expertise in synthesizing complex compounds has positioned him as a valuable asset in the field of medicinal chemistry.

Collaborations

Rozancev has worked alongside notable colleagues such as Lothar Zenker and Helmut Wunderlich. Their collaborative efforts have further enhanced the research and development of innovative medical solutions.

Conclusion

Grigorij G Rozancev's contributions to the field of cerebroprotective compounds highlight his importance as an inventor. His patent for N-acyl-4-phenyl-pyrrolidin-2-ones represents a significant advancement in the treatment of cerebral functional disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…